The global NAD+ Therapy market size is predicted to grow from US$ 105 million in 2025 to US$ 135 million in 2031; it is expected to grow at a CAGR of 4.2% from 2025 to 2031.
NAD+ therapy is a medical treatment in which nicotinamide adenine dinucleotide (NAD+) is injected directly into the bloodstream. NAD+ is an important coenzyme involved in cellular energy metabolism and repair processes. By injecting it intravenously, NAD+ is quickly and efficiently absorbed into the body, avoiding digestive depletion. This treatment is widely used to improve energy levels, enhance cognitive function, and promote cellular repair.
United States market for NAD+ Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for NAD+ Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for NAD+ Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key NAD+ Therapy players cover The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淣AD+ Therapy Industry Forecast鈥� looks at past sales and reviews total world NAD+ Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected NAD+ Therapy sales for 2025 through 2031. With NAD+ Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NAD+ Therapy industry.
This Insight Report provides a comprehensive analysis of the global NAD+ Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NAD+ Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global NAD+ Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NAD+ Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NAD+ Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of NAD+ Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
NAD+ Vitamin Mix Injection
Pure NAD+ Injection
Segmentation by Application:
Clinic
Hospital
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
The Wellness Lab
Conciergemdla
Azivmedics
Reset IV
Thedripclub
Toronto Functional Medicine Centre
Mobileivmedics
Rocky Mountain Ivmedics
Seaside Skin Care
Premiumhealth
Effect Doctors
Nadclinic
Hydrate IV Bar
LIVV Natural
BioReset Medical
IV Boost UK
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NAD+ Therapy Market Size (2020-2031)
2.1.2 NAD+ Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for NAD+ Therapy by Country/Region (2020, 2024 & 2031)
2.2 NAD+ Therapy Segment by Type
2.2.1 NAD+ Vitamin Mix Injection
2.2.2 Pure NAD+ Injection
2.3 NAD+ Therapy Market Size by Type
2.3.1 NAD+ Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global NAD+ Therapy Market Size Market Share by Type (2020-2025)
2.4 NAD+ Therapy Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Other
2.5 NAD+ Therapy Market Size by Application
2.5.1 NAD+ Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global NAD+ Therapy Market Size Market Share by Application (2020-2025)
3 NAD+ Therapy Market Size by Player
3.1 NAD+ Therapy Market Size Market Share by Player
3.1.1 Global NAD+ Therapy Revenue by Player (2020-2025)
3.1.2 Global NAD+ Therapy Revenue Market Share by Player (2020-2025)
3.2 Global NAD+ Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NAD+ Therapy by Region
4.1 NAD+ Therapy Market Size by Region (2020-2025)
4.2 Global NAD+ Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas NAD+ Therapy Market Size Growth (2020-2025)
4.4 APAC NAD+ Therapy Market Size Growth (2020-2025)
4.5 Europe NAD+ Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa NAD+ Therapy Market Size Growth (2020-2025)
5 Americas
5.1 Americas NAD+ Therapy Market Size by Country (2020-2025)
5.2 Americas NAD+ Therapy Market Size by Type (2020-2025)
5.3 Americas NAD+ Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NAD+ Therapy Market Size by Region (2020-2025)
6.2 APAC NAD+ Therapy Market Size by Type (2020-2025)
6.3 APAC NAD+ Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe NAD+ Therapy Market Size by Country (2020-2025)
7.2 Europe NAD+ Therapy Market Size by Type (2020-2025)
7.3 Europe NAD+ Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NAD+ Therapy by Region (2020-2025)
8.2 Middle East & Africa NAD+ Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa NAD+ Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global NAD+ Therapy Market Forecast
10.1 Global NAD+ Therapy Forecast by Region (2026-2031)
10.1.1 Global NAD+ Therapy Forecast by Region (2026-2031)
10.1.2 Americas NAD+ Therapy Forecast
10.1.3 APAC NAD+ Therapy Forecast
10.1.4 Europe NAD+ Therapy Forecast
10.1.5 Middle East & Africa NAD+ Therapy Forecast
10.2 Americas NAD+ Therapy Forecast by Country (2026-2031)
10.2.1 United States Market NAD+ Therapy Forecast
10.2.2 Canada Market NAD+ Therapy Forecast
10.2.3 Mexico Market NAD+ Therapy Forecast
10.2.4 Brazil Market NAD+ Therapy Forecast
10.3 APAC NAD+ Therapy Forecast by Region (2026-2031)
10.3.1 China NAD+ Therapy Market Forecast
10.3.2 Japan Market NAD+ Therapy Forecast
10.3.3 Korea Market NAD+ Therapy Forecast
10.3.4 Southeast Asia Market NAD+ Therapy Forecast
10.3.5 India Market NAD+ Therapy Forecast
10.3.6 Australia Market NAD+ Therapy Forecast
10.4 Europe NAD+ Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market NAD+ Therapy Forecast
10.4.2 France Market NAD+ Therapy Forecast
10.4.3 UK Market NAD+ Therapy Forecast
10.4.4 Italy Market NAD+ Therapy Forecast
10.4.5 Russia Market NAD+ Therapy Forecast
10.5 Middle East & Africa NAD+ Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market NAD+ Therapy Forecast
10.5.2 South Africa Market NAD+ Therapy Forecast
10.5.3 Israel Market NAD+ Therapy Forecast
10.5.4 Turkey Market NAD+ Therapy Forecast
10.6 Global NAD+ Therapy Forecast by Type (2026-2031)
10.7 Global NAD+ Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market NAD+ Therapy Forecast
11 Key Players Analysis
11.1 The Wellness Lab
11.1.1 The Wellness Lab Company Information
11.1.2 The Wellness Lab NAD+ Therapy Product Offered
11.1.3 The Wellness Lab NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 The Wellness Lab Main Business Overview
11.1.5 The Wellness Lab Latest Developments
11.2 Conciergemdla
11.2.1 Conciergemdla Company Information
11.2.2 Conciergemdla NAD+ Therapy Product Offered
11.2.3 Conciergemdla NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Conciergemdla Main Business Overview
11.2.5 Conciergemdla Latest Developments
11.3 Azivmedics
11.3.1 Azivmedics Company Information
11.3.2 Azivmedics NAD+ Therapy Product Offered
11.3.3 Azivmedics NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Azivmedics Main Business Overview
11.3.5 Azivmedics Latest Developments
11.4 Reset IV
11.4.1 Reset IV Company Information
11.4.2 Reset IV NAD+ Therapy Product Offered
11.4.3 Reset IV NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Reset IV Main Business Overview
11.4.5 Reset IV Latest Developments
11.5 Thedripclub
11.5.1 Thedripclub Company Information
11.5.2 Thedripclub NAD+ Therapy Product Offered
11.5.3 Thedripclub NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Thedripclub Main Business Overview
11.5.5 Thedripclub Latest Developments
11.6 Toronto Functional Medicine Centre
11.6.1 Toronto Functional Medicine Centre Company Information
11.6.2 Toronto Functional Medicine Centre NAD+ Therapy Product Offered
11.6.3 Toronto Functional Medicine Centre NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Toronto Functional Medicine Centre Main Business Overview
11.6.5 Toronto Functional Medicine Centre Latest Developments
11.7 Mobileivmedics
11.7.1 Mobileivmedics Company Information
11.7.2 Mobileivmedics NAD+ Therapy Product Offered
11.7.3 Mobileivmedics NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Mobileivmedics Main Business Overview
11.7.5 Mobileivmedics Latest Developments
11.8 Rocky Mountain Ivmedics
11.8.1 Rocky Mountain Ivmedics Company Information
11.8.2 Rocky Mountain Ivmedics NAD+ Therapy Product Offered
11.8.3 Rocky Mountain Ivmedics NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Rocky Mountain Ivmedics Main Business Overview
11.8.5 Rocky Mountain Ivmedics Latest Developments
11.9 Seaside Skin Care
11.9.1 Seaside Skin Care Company Information
11.9.2 Seaside Skin Care NAD+ Therapy Product Offered
11.9.3 Seaside Skin Care NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Seaside Skin Care Main Business Overview
11.9.5 Seaside Skin Care Latest Developments
11.10 Premiumhealth
11.10.1 Premiumhealth Company Information
11.10.2 Premiumhealth NAD+ Therapy Product Offered
11.10.3 Premiumhealth NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Premiumhealth Main Business Overview
11.10.5 Premiumhealth Latest Developments
11.11 Effect Doctors
11.11.1 Effect Doctors Company Information
11.11.2 Effect Doctors NAD+ Therapy Product Offered
11.11.3 Effect Doctors NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Effect Doctors Main Business Overview
11.11.5 Effect Doctors Latest Developments
11.12 Nadclinic
11.12.1 Nadclinic Company Information
11.12.2 Nadclinic NAD+ Therapy Product Offered
11.12.3 Nadclinic NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Nadclinic Main Business Overview
11.12.5 Nadclinic Latest Developments
11.13 Hydrate IV Bar
11.13.1 Hydrate IV Bar Company Information
11.13.2 Hydrate IV Bar NAD+ Therapy Product Offered
11.13.3 Hydrate IV Bar NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Hydrate IV Bar Main Business Overview
11.13.5 Hydrate IV Bar Latest Developments
11.14 LIVV Natural
11.14.1 LIVV Natural Company Information
11.14.2 LIVV Natural NAD+ Therapy Product Offered
11.14.3 LIVV Natural NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 LIVV Natural Main Business Overview
11.14.5 LIVV Natural Latest Developments
11.15 BioReset Medical
11.15.1 BioReset Medical Company Information
11.15.2 BioReset Medical NAD+ Therapy Product Offered
11.15.3 BioReset Medical NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 BioReset Medical Main Business Overview
11.15.5 BioReset Medical Latest Developments
11.16 IV Boost UK
11.16.1 IV Boost UK Company Information
11.16.2 IV Boost UK NAD+ Therapy Product Offered
11.16.3 IV Boost UK NAD+ Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 IV Boost UK Main Business Overview
11.16.5 IV Boost UK Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
